Search Results - charles+holjencin

1 Results Sort By:
Advancements of 599 peptide carrier design through stereochemical and/or amino acid modifications
Technology: Researchers at MUSC have developed a cell-penetrating peptide (CPP) specifically designed to overcome challenges associated with small interfering RNA (siRNA)-drug delivery for cancer treatment. Investigators previously generated the 599 peptide that silenced the CIP2A oncogene and suppressed tumor growth in vivo (Figure 1). Figure...
Published: 1/28/2021   |   Inventor(s): Andrew Jakymiw, Charles Holjencin
Keywords(s):  
Category(s): Therapeutic
© 2021. All Rights Reserved. Powered by Inteum